Sphingosine-1-phosphate receptor subtypes 1, 3, and 5 (S1PR1, S1PR3, S1PR5)

Sphingosine-1-phosphate receptor subtypes 1, 3, and 5 (S1PR1, S1PR3, S1PR5) are G protein-coupled receptors that mediate cellular responses to the bioactive lipid sphingosine-1-phosphate. They play prominent roles in immune cell trafficking, vascular development, heart rate regulation, and neurobiology. These receptors serve as important therapeutic targets for drug development in autoimmune, neurodegenerative, cancer, and cardiovascular diseases. Drugs targeting these receptors—including fingolimod, siponimod, and ozanimod—modulate immune responses by sequestering lymphocytes and affect other critical physiological functions. Selectivity for individual subtypes is an ongoing focus in drug design, as off-target effects can cause notable safety concerns such as bradycardia and immunosuppression.

Other names

S1PR1 (EDG1)S1PR3 (EDG3)S1PR5 (EDG8)S1P receptor 1S1P receptor 3S1P receptor 5

Agonism (activation causes receptor internalization, immune cell sequestration, inhibition of egress of lymphocytes in S1PR1). Antagonism/inverse agonism (blocks receptor signaling, e.g., selective antagonists for S1PR5). Modulation of immune cell egress. Regulation of vascular tone/protection against ischemia.